| Overview |
| bs-9915R-Cy3 |
| Alpha 1 acid glycoprotein 2 Polyclonal Antibody, Cy3 Conjugated |
| WB, IF(IHC-P) |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Orosomucoid 2 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5005 |
| Orosomucoid-2; AGP 2; AGP-2; AGP B; AGP-B; AGP2; Alpha 1 acid glycoprotein 2; Alpha 1 acid glycoprotein type 2; OMD 2; OMD2; OMD-2; ORM 2; ORM2; ORM-2; Orosomucoid2; A1AG2_HUMAN. |
| Orosomucoid 2 is a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however Orosomucoid 2 appears to function in modulating the activity of the immune system during the acute-phase reaction. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz